| 1 | Conventional Glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone) | [7] Acetate Acetate, Cortisone, Cortisone acetate, Dexamethasone, Hydrocortisone, Prednisolone, Prednisone | [6] Hydrocortisone
Hydrocortisone
,
Dexamethasone
,
Prednisolone
,
Prednisone
,
Cortisone acetate
,
Cortisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 81 81 💬
|
| 2 | Cyclophosphamide followed by methotrexate (azathioprine) + glucocorticoids or methotrexate (azathioprine) + glucocorticoids | [3] Azathioprine Azathioprine, Cyclophosphamide, Methotrexate | [4] Methotrexate
Methotrexate
,
Azathioprine
,
Cyclophosphamide
,
Cyclophosphamide
💬
| [2] DHFR DHFR, DHFR2 💬
| [5] Antifolate resistance Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 💬 | [1] 44 44 💬
|
| 3 | Cyclosporin A+Glucocorticoids | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 60 60, 62 💬
|
| 4 | GlucoCorticoid | - | - | - | - | [2] 46 46, 228 💬
|
| 5 | Glucocorticoid (GC) | - | - | - | - | [2] 43 43, 44 💬
|
| 6 | Glucocorticoid (prednisone or prednisolone) | [2] Prednisolone Prednisolone, Prednisone | [2] Prednisolone
Prednisolone
,
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 84 84 💬
|
| 7 | Glucocorticoid + cytoxan | - | - | - | - | [1] 222 222 💬
|
| 8 | Glucocorticoid + tacrolimus | [1] Tacrolimus Tacrolimus | [2] Tacrolimus
Tacrolimus
,
Tacrolimus
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 222 222 💬
|
| 9 | Glucocorticoid Agent | - | - | - | - | [1] 46 46 💬
|
| 10 | Glucocorticoid combined with cyclophosphamide induction + maintenance | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [1] 222 222 💬
|
| 11 | Glucocorticoid Treatment | - | - | - | - | [1] 41 41 💬
|
| 12 | Glucocorticoids | - | - | - | - | [8] 40 40, 41, 43, 44, 60, 62, 75, 300 💬
|
| 13 | Glucocorticoids (GC) | - | - | - | - | [2] 43 43, 44 💬
|
| 14 | Glucocorticoids (permitted,not necessary) | - | - | - | - | [1] 46 46 💬
|
| 15 | Glucocorticoids - Reduced Dose | - | - | - | - | [2] 43 43, 44 💬
|
| 16 | Glucocorticoids - Standard Dose | - | - | - | - | [2] 43 43, 44 💬
|
| 17 | Glucocorticoids [Reduced Dose] | - | - | - | - | [2] 43 43, 44 💬
|
| 18 | Glucocorticoids [Standard Dose] | - | - | - | - | [2] 43 43, 44 💬
|
| 19 | Gusperimus + glucocorticoids | [1] Gusperimus Gusperimus | [1] Gusperimus
Gusperimus
💬
| - | - | [1] 44 44 💬
|
| 20 | Levamisole+cyclosporin A+Glucocorticoids | [2] Cyclosporine Cyclosporine, Levamisole | [2] Cyclosporine
Cyclosporine
,
Levamisole
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 60 60, 62 💬
|
| 21 | Methylprednisolone (or other glucocorticoid) | [1] Methylprednisolone Methylprednisolone | [1] Methylprednisolone
Methylprednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 43 43 💬
|
| 22 | Standard glucocorticoid therapy | - | - | - | - | [1] 81 81 💬
|
| 23 | Tocilizumab + Glucocorticoids (GCs) | [1] Tocilizumab Tocilizumab | [1] Tocilizumab
Tocilizumab
💬
| [1] IL6R IL6R 💬
| [12] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 41 41 💬
|
| 24 | Ursodeoxycholic acid+Low Dose Glucocorticoid(Methylprednisolone) | [2] Methylprednisolone Methylprednisolone, Ursodeoxycholic acid | [2] Methylprednisolone
Methylprednisolone
,
Ursodiol
💬
| [2] NR1H4 NR1H4, NR3C1 💬
| [2] Bile secretion Bile secretion, Neuroactive ligand-receptor interaction 💬 | [1] 93 93 💬
|